Skip to main content

Genedata Partners with EC-Backed Infections and Cancer Consortium

NEW YORK, June 27 (GenomeWeb News) - Genedata today announced a partnership with the Infections and Cancer (INCA) consortium, a European Commission-backed research program to discover the role of chronic infection in the development of cancer.

 

Genedata will provide research informatics to support the consortium's research. Financial details were not disclosed.

 

"INCA will help researchers develop new prevention measures and treatments against cancers such as leukemia, stomach cancer, and cervical cancer," Thomas Schulz, INCA's principal coordinator, said in a statement. The consortium will focus on five viruses and the Helicobacter pylori bacterium, Genedata said.

 

The four-year program kicked off in January and will receive €12.6 million ($15.9 million) of EC funding as part of Europe's Sixth Framework Life-Science-Health program. The consortium includes 30 research organizations from 13 European countries.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.